Literature DB >> 21737786

Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2.

Jochen Pöling1, Marten Szibor, Silvia Schimanski, Marie-Elisabeth Ingelmann, Wolfgang Rees, Praveen Gajawada, Zaber Kochfar, Holger Lörchner, Isabelle Salwig, Jae-Young Shin, Karsten Wiebe, Thomas Kubin, Henning Warnecke, Thomas Braun.   

Abstract

OBJECTIVE: Collateral artery growth or arteriogenesis is the primary means of the circulatory system to maintain blood flow in the face of major arterial occlusions. Arteriogenesis depends on activation of fibroblast growth factor (FGF) receptors, but relatively little is known about downstream mediators of FGF signaling. METHODS AND
RESULTS: We screened for signaling components that are activated in response to administration of FGF-2 to cultured vascular smooth muscle cells (VSMCs) and detected a significant increase of Rap2 but not of other Ras family members, which corresponded to a strong upregulation of Rap2 and C-Raf in growing collaterals from rabbits with femoral artery occlusion. Small interfering RNAs directed against Rap2 did not affect FGF-2 induced proliferation of VSMC but strongly inhibited their migration. Inhibition of FGF receptor-1 (FGFR1) signaling by infusion of a sulfonic acid polymer or infection with a dominant-negative FGFR1 adenovirus inhibited Rap2 upregulation and collateral vessel growth. Similarly, expression of dominant-negative Rap2 blocked arteriogenesis, whereas constitutive active Rap2 enhanced collateral vessel growth.
CONCLUSIONS: Rap2 is part of the arteriogenic program and acts downstream of the FGFR1 to stimulate VSMC migration. Specific modulation of Rap2 might be an attractive target to manipulate VSMC migration, which plays a role in numerous pathological processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737786     DOI: 10.1161/ATVBAHA.111.232835

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

Review 1.  Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?

Authors:  Petra Rocic
Journal:  Vascul Pharmacol       Date:  2012-02-09       Impact factor: 5.773

2.  Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularization in dermal wounds.

Authors:  Koung Li Kim; Sun-Hwa Song; Kyu-Sil Choi; Wonhee Suh
Journal:  Tissue Eng Part A       Date:  2013-07-27       Impact factor: 3.845

3.  Multi-omic Analysis of Non-human Primate Heart after Partial-body Radiation with Minimal Bone Marrow Sparing.

Authors:  Stephanie Zalesak-Kravec; Weiliang Huang; Pengcheng Wang; Jianshi Yu; Tian Liu; Amy E Defnet; Alexander R Moise; Ann M Farese; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2021-10-01       Impact factor: 2.922

4.  Kv7 Channel Activation Underpins EPAC-Dependent Relaxations of Rat Arteries.

Authors:  Jennifer B Stott; Vincenzo Barrese; Iain A Greenwood
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-27       Impact factor: 8.311

5.  Macrophages in collateral arteriogenesis.

Authors:  Erik Fung; Armin Helisch
Journal:  Front Physiol       Date:  2012-09-24       Impact factor: 4.566

6.  Increased neointimal thickening in dystrophin-deficient mdx mice.

Authors:  Uwe Rauch; Annelie Shami; Feng Zhang; Virginie Carmignac; Madeleine Durbeej; Anna Hultgårdh-Nilsson
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

7.  BRAF activates PAX3 to control muscle precursor cell migration during forelimb muscle development.

Authors:  Jaeyoung Shin; Shuichi Watanabe; Soraya Hoelper; Marcus Krüger; Sawa Kostin; Jochen Pöling; Thomas Kubin; Thomas Braun
Journal:  Elife       Date:  2016-12-01       Impact factor: 8.140

Review 8.  Cellular and pharmacological targets to induce coronary arteriogenesis.

Authors:  Maurits R Hollander; Anton J G Horrevoets; Niels van Royen
Journal:  Curr Cardiol Rev       Date:  2014-02

9.  Endothelial-Specific EphA4 Negatively Regulates Native Pial Collateral Formation and Re-Perfusion following Hindlimb Ischemia.

Authors:  Benjamin Okyere; Kaavya Giridhar; Amanda Hazy; Miao Chen; David Keimig; Robert C Bielitz; Hehuang Xie; Jia-Qiang He; William R Huckle; Michelle H Theus
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.

Authors:  Weier Qi; Qian Li; Chong Wee Liew; Christian Rask-Madsen; Samuel M Lockhart; Lars Melholt Rasmussen; Yu Xia; Xuanchun Wang; Mogher Khamaisi; Kevin Croce; George L King
Journal:  Diabetologia       Date:  2016-12-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.